{"data":{"id":"us/37-cfr-appendix-g-to-subpart-g-of-part-1","jurisdiction":"us","citation":"37 CFR Appendix G to Subpart G of Part 1","heading":"Appendix G to Subpart G of Part 1—Numeric Identifiers","body":"Numeric identifier Definition Comments and format Mandatory (M) or optional (O)\n\u003c110\u003e Applicant If Applicant is inventor, then preferably max. of 10 names; one name per line; preferable format: Surname, Other Names and/or Initials M.\n\u003c120\u003e Title of Invention M.\n\u003c130\u003e File Reference Personal file reference M when filed prior to assignment or appl. number.\n\u003c140\u003e Current Application Number Specify as: US 09/999,999 or PCT/US09/99999 M, if available.\n\u003c141\u003e Current Filing Date Specify as: yyyy-mm-dd M, if available.\n\u003c150\u003e Prior Application Number Specify as: US 09/999,999 or PCT/US09/99999 M, if applicable include priority documents under 35 U.S.C. 119 and 120.\n\u003c151\u003e Prior Application Filing Date Specify as: yyyy-mm-dd M, if applicable.\n\u003c160\u003e Number of SEQ ID NOs Count includes total number of SEQ ID NOs M.\n\u003c170\u003e Software Name of software used to create the “Sequence Listing” O.\n\u003c210\u003e SEQ ID NO:#: Response shall be an integer representing the SEQ ID NO shown M.\n\u003c211\u003e Length Respond with an integer expressing the number of bases or amino acid residues M.\n\u003c212\u003e Type Whether presented sequence molecule is DNA, RNA, or PRT (protein). If a nucleotide sequence contains both DNA and RNA fragments, the type shall be “DNA.” In addition, the combined DNA/RNA molecule shall be further described in the \u003c220\u003e to \u003c223\u003e feature section M.\n\u003c213\u003e Organism Scientific name, i.e., Genus/species, Unknown or Artificial Sequence. In addition, the “Unknown” or “Artificial Sequence” organisms shall be further described in the \u003c220\u003e to \u003c223\u003e feature section M.\n\u003c220\u003e Feature Leave blank after \u003c220\u003e. \u003c221-223\u003e provide for a description of points of biological significance in the sequence M, under the following conditions: If “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence; if ORGANISM is “Artificial Sequence” or “Unknown”; if molecule is combined DNA/RNA.\n\u003c221\u003e Name/Key Provide appropriate identifier for feature, from WIPO Standard ST.25 (2009), Appendices E and F to this subpart M, under the following conditions: If “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence.\n\u003c222\u003e Location Specify location within sequence; where appropriate, state number of first and last bases/amino acids in feature M, under the following conditions: If “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence.\n\u003c223\u003e Other Information Other relevant information; four lines maximum M, under the following conditions: If “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence; if ORGANISM is “Artificial Sequence” or “Unknown”; if molecule is combined DNA/RNA.\n\u003c300\u003e Publication Information Leave blank after \u003c30\u003e O.\n\u003c301\u003e Authors Preferably max. of 10 named authors of publication; specify one name per line; preferable format: Surname, Other Names and/or Initials O.\n\u003c302\u003e Title O.\n\u003c303\u003e Journal O.\n\u003c304\u003e Volume O.\n\u003c305\u003e Issue O.\n\u003c306\u003e Pages O.\n\u003c307\u003e Date Journal date on which data published; specify as yyyy-mm-dd, MMM-yyyy or Season-yyyy O.\n\u003c308\u003e Database Accession Number Accession number assigned by database, including database name O.\n\u003c309\u003e Database Entry Date Date of entry in database; specify as yyyy-mm-dd or MMM-yyyy O.\n\u003c310\u003e Patent Document Number Document number; for patent-type citations only. Specify as, for example, US 09/999,999 O.\n\u003c311\u003e Patent Filing Date Document filing date, for patent-type citations only; specify as yyyy-mm-dd O.\n\u003c312\u003e Publication Date Document publication date, for patent-type citations only; specify as yyyy-mm-dd O.\n\u003c313\u003e Relevant Residues FROM (position) TO (position) O.\n\u003c400\u003e Sequence SEQ ID NO should follow the numeric identifier and should appear on the line preceding the actual sequence M.","path":["Title 37—Patents, Trademarks, and Copyrights","CHAPTER I—UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE","SUBCHAPTER A—GENERAL","PART 1—RULES OF PRACTICE IN PATENT CASES","Subpart G—Biotechnology Invention Disclosures"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-37.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:25:45Z","sha256":"b4685a730356267b978cbee4d4de64b6b7e9b331bb99445b20f365fb83d08a5b","source_id":"us-cfr","stale":true,"prev":"us/37-cfr-appendix-f-to-subpart-g-of-part-1","next":"us/37-cfr-1.902"},"notice":"GroundRules: Original legal text. Not legal advice."}